GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 45 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 202,100 | $2,318,000 | 1.99% |
| Gerry Farber, LLC | 52,000 | $596,000 | 1.03% |
| Granite Point Capital Management, L.P. | 115,000 | $1,319,000 | 0.94% |
| 683 Capital Management, LLC | 158,735 | $1,821,000 | 0.71% |
| SPHERA FUNDS MANAGEMENT LTD. | 170,000 | $1,950,000 | 0.44% |
| Knoll Capital Management, LLC | 65,000 | $746,000 | 0.39% |
| Healthcare Value Capital, LLC | 50,000 | $574,000 | 0.38% |
| Park West Asset Management LLC | 200,000 | $2,294,000 | 0.26% |
| Perceptive Advisors | 75,000 | $860,000 | 0.09% |
| HIGHLAND CAPITAL MANAGEMENT LP | 126,956 | $1,456,000 | 0.06% |